Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2001
10/17/2001CN1073157C 转录因子aprf Transcription factor aprf
10/17/2001CN1073119C Method and compsns. for dry powder formulation of interferons
10/17/2001CN1073118C Diagnostics virus of hepatitis C
10/17/2001CN1073117C Antibiotic peptide and prodn. method and use thereof
10/17/2001CN1073116C Metal-bonding cystein-free peptides, process for producing them and its pharmaceutical preparation
10/17/2001CN1073115C WS7622A mono-or di-sulfate process for prepn. thereof
10/16/2001USRE37411 Expression cassette for antisense expression of ribozyme
10/16/2001US6303847 Nucleotide sequence; for transgenic plants
10/16/2001US6303779 Process for isolating and purifying viruses and sugars from plant sources
10/16/2001US6303772 Cyclin D binding factor, and uses thereof
10/16/2001US6303771 Pth
10/16/2001US6303770 Nucleic acids encoding mammalian alpha helical protein-1
10/16/2001US6303769 Lerk-5 dna
10/16/2001US6303768 Methuselah gene, compositions and methods of use
10/16/2001US6303765 Polynucleotide which codes for protein of defined amino acids sequence; recombinant production; anticarcinogenic agents; antiarthritic agents; treatment of immune disorders such as multiple sclerosis and myasthenia gravis; diagnosis
10/16/2001US6303764 Synthesis of 4,7-dialkyl chromogenic glycosides of N-acetylneuraminic acids
10/16/2001US6303756 Tumor associated nucleic acids and uses therefor
10/16/2001US6303755 Therapeutic multispecific compounds comprised of anti-FCA receptor antibodies
10/16/2001US6303754 Recombinant procvf
10/16/2001US6303753 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
10/16/2001US6303751 Human metabotropic glutamate receptor and related DNA compounds
10/16/2001US6303750 Amino acid sequences; diagnosis and treatment of rheumatoid arthritis; antiarthritic agents
10/16/2001US6303749 Amino acid sequences; for modification of feeding behavior
10/16/2001US6303576 Contacting cell with modulating agent that comprises internalization moiety and compound having amino acid sequencel peptide analogue or peptidomimetic of compound which retains ablity to inhibit beta-catenin mediated response
10/16/2001US6303574 Scr SH3 binding peptides and methods of isolating and using same
10/16/2001US6303571 To screen for antibacterial compounds; genetic immunization; therapy and prophylaxis
10/16/2001US6303568 Therapeutic antimicrobial polypeptides, their use and methods for preparation
10/16/2001US6303567 For diagnosis and therapy of amyloidogenic diseases such as alzheimer's disease
10/16/2001US6303388 Process for preparing novel ice-controlling molecules
10/16/2001US6303382 Formation of and methods for the production of large bacillus thuringiensis crystals with increased pesticidal activity
10/16/2001US6303381 Nucleotide sequences; for use as tools in genetic analysis
10/16/2001US6303379 Transfected cells for use in treatment of genetic disorder
10/16/2001US6303377 Biotin biosynthesis in bacillus subtilis
10/16/2001US6303373 Method of measuring plasma membrane targeting of GLUT4
10/16/2001US6303372 cDNA molecule encoding human CIF130
10/16/2001US6303371 Method of purified rAAV vector production in non-human cell line transfected with cocksackie and adenovirus receptor
10/16/2001US6303369 Plasmid for generating preferential polypeptides; for use as a tool in genetic engineering
10/16/2001US6303364 Bacillus thuringiensis toxins with improved activity
10/16/2001US6303362 Generating genetically engineered viral genome; provide plasmids, incubate plasmids with restriction enzyme, mix products and ligate, screen libraries
10/16/2001US6303348 DNA coding for protein which confers on bacterium escherichia coli resistance to L-homoserine and method for producing L-amino acids
10/16/2001US6303344 Methods and compositions for polypeptide engineering
10/16/2001US6303341 Genetically engineered antibody for use in immunotherapy
10/16/2001US6303340 Isolating preferential fusion protein; express fusion protein in cell, recover inclusion bodies, split fusion protein, solubilize split products, isolate protein
10/16/2001US6303339 Nucleotide sequences coding nucleoprotein epitopes; for use in the diagnosis of autoimmune diseases
10/16/2001US6303338 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of mammary gland cancer, and pathologic defects
10/16/2001US6303336 Polypeptide for the use in the prevention on viral infection; viricides
10/16/2001US6303335 Transcription factor E2F-4
10/16/2001US6303334 Nucleotide sequences coding polypeptides for use in as a viricide and in gene therapy
10/16/2001US6303333 Expression vector which codes polypeptides for the diagnosis and treatment of cancer, dietetics, inflammation, cardiovascular disorders, crohn's diseases, neuropathies and immune defects
10/16/2001US6303332 Corn cDNA encoding southern leaf blight resistance
10/16/2001US6303331 Vertebrate apoptosis gene: compositions and methods
10/16/2001US6303320 Polypeptide of protein P140 and DNAs encoding it
10/16/2001US6303319 Cell based assay for identifying sh2-domain-specific signal transducer antagonist
10/16/2001US6303318 Detecting urogenital hyperplasia; isolate proteases in sample, detecting and classify preferential proteases in sample, compare to control, amplified enzyme concentration indicates hyperplasia
10/16/2001US6303317 Preferential amino acid sequence probe; for as a diagnostic detection tool
10/16/2001US6303315 One step sample preparation and detection of nucleic acids in complex biological samples
10/16/2001US6303297 Apparatus storing and evaluating nucleotide sequences; for diagnosis and detection of genotype defects
10/16/2001US6303295 Selenoproteins, coding sequences and methods
10/16/2001US6303292 Geneticlly engineered viral polypeptides; for use in diagnosis and treatment of viral infection
10/16/2001US6303287 Evaluating binding activity of particles to preferential protein domains; mix binding domain and chemical particles
10/16/2001US6303178 Emulsifying and whipping capabilities and is useful for the production of food products including ices, meringues, spread pastes, beverages
10/16/2001US6303128 Method for protein expression
10/16/2001US6303126 Treatment of fibrosis by HGF
10/16/2001US6303121 Method of using human receptor protein 4-1BB
10/16/2001CA2176236C Tyrosinase-activator protein fusion enzyme
10/16/2001CA2144104C Peptide derivatives having binding activity to modified low density lipoprotein
10/16/2001CA2087969C Protease resistant pdgf and methods of use
10/16/2001CA2044626C Type a platelet-derived growth factor receptor gene
10/16/2001CA2036463C Synthetic peptides specific for the detection of antibodies to hcv, diagnosis of hcv infection and prevention thereof as vaccines
10/16/2001CA2031164C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
10/16/2001CA2001774C Method for identifying active domains and amino acid residues in polypeptides and hormone variants
10/16/2001CA1341305C Dna binding proteins including androgen receptor
10/14/2001CA2344183A1 Glycoprotein having inhibitory activity against helicobacter pylori colonization
10/12/2001CA2335109A1 Cxcr4 agonist treatment of hematopoietic cells
10/11/2001WO2001075449A1 Method of examining cancer by assaying autoantibody against mdm2 and reagent therefor
10/11/2001WO2001075448A2 Methods and compositions for detecting larval taenia solium with a cloned diagnostic antigen
10/11/2001WO2001075440A2 Schizophrenia related genes
10/11/2001WO2001075435A2 Fluorescence assay for gamma-secretase activity and inhibitors
10/11/2001WO2001075179A2 Preprocalcitonin as tumor rejection antigen precursor and uses thereof
10/11/2001WO2001075167A1 Reverse genetic strategy for identifying functional mutations in genes of known sequence
10/11/2001WO2001075158A1 Incrementally truncated nucleic acids and methods of making same
10/11/2001WO2001075147A1 Method of concentrating and recovering a viral enzyme activity from biological samples
10/11/2001WO2001075140A1 HYBRID CYTOKINE OF IL-7 AND β-CHAIN OF HEPATOCYTE GROWTH FACTOR
10/11/2001WO2001075135A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders
10/11/2001WO2001075134A1 The adeno-associated virus which contains the growth hormone gene or related genes and their usage
10/11/2001WO2001075133A1 Secreted proteins and polynucleotides encoding them
10/11/2001WO2001075132A2 Method for producing authentic cytokines in plants
10/11/2001WO2001075129A1 AtRSp GENE PROMOTERS
10/11/2001WO2001075126A1 Novel polypeptide--- a human ribosomal protein s18-9 and polynucleotide encoding it
10/11/2001WO2001075124A1 Novel polypeptide -- a human regulatory transcript factor 9 and polynucleotide encoding it
10/11/2001WO2001075123A1 Novel polypeptide--- a human hepatic nuclear factor 12 and polynucleotide encoding it
10/11/2001WO2001075122A1 Novel polypeptide---a human cytochrome comprising protein 10 and polynucleotide encoding it
10/11/2001WO2001075116A2 ISOLATED NUCLEIC ACIDS FROM MICROMONOSPORA ROSARIA PLASMID pMR2 AND VECTORS MADE THEREFROM
10/11/2001WO2001075115A1 Gene 763 of phytopathogenic fungus magnaporthe grisea and use thereof for identifying fungicidal compounds
10/11/2001WO2001075114A2 Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
10/11/2001WO2001075113A2 Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof
10/11/2001WO2001075112A2 Chlamydia antigens and corresponding dna fragments and uses thereof
10/11/2001WO2001075111A2 Chlamydia antigens and corresponding dna fragments and uses thereof
10/11/2001WO2001075110A2 Mucin-1 specific binding members and methods of use thereof
10/11/2001WO2001075108A1 Human ion channel protein and polynucleotides encoding the same